Cargando…

Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26

OBJECTIVE: Testicular cancer (TC) is the most common cancer in young men, and its incidence is increasing. The low mortality rate makes quality of life (QOL) an important issue in this patient group. This study aimed to develop a supplementary module of the EORTC QLQ-C30 questionnaire to assess TC-s...

Descripción completa

Detalles Bibliográficos
Autores principales: Holzner, Bernhard, Efficace, Fabio, Basso, Umberto, Johnson, Colin D., Aaronson, Neil K., Arraras, Juan I., Smith, Allan B., Chow, Edward, Oberguggenberger, Anne S., Bottomley, Andrew, Steiner, Hannes, Incrocci, Luca, Giesinger, Johannes M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576569/
https://www.ncbi.nlm.nih.gov/pubmed/22407356
http://dx.doi.org/10.1007/s11136-012-0147-1
_version_ 1782259868912058368
author Holzner, Bernhard
Efficace, Fabio
Basso, Umberto
Johnson, Colin D.
Aaronson, Neil K.
Arraras, Juan I.
Smith, Allan B.
Chow, Edward
Oberguggenberger, Anne S.
Bottomley, Andrew
Steiner, Hannes
Incrocci, Luca
Giesinger, Johannes M.
author_facet Holzner, Bernhard
Efficace, Fabio
Basso, Umberto
Johnson, Colin D.
Aaronson, Neil K.
Arraras, Juan I.
Smith, Allan B.
Chow, Edward
Oberguggenberger, Anne S.
Bottomley, Andrew
Steiner, Hannes
Incrocci, Luca
Giesinger, Johannes M.
author_sort Holzner, Bernhard
collection PubMed
description OBJECTIVE: Testicular cancer (TC) is the most common cancer in young men, and its incidence is increasing. The low mortality rate makes quality of life (QOL) an important issue in this patient group. This study aimed to develop a supplementary module of the EORTC QLQ-C30 questionnaire to assess TC-specific aspects of QOL. METHODS: Questionnaire development was conducted according to guidelines from the EORTC Quality of Life Group. Phase I comprised generation of QOL issues relevant to TC patients through a literature search and interviews with patients and experts. Phase II included operationalization and assessment of item relevance. In phase III, items were pre-tested in a cross-cultural sample to assess issues such as understandability and intrusiveness of items. RESULTS: In phase I and II, an initial list of 69 QOL issues possibly relevant to TC patients was refined through patient and expert interviews. The remaining 37 issues were operationalized into items and assessed for relevance and priority in an expert sample (n = 28) and a patient sample (n = 62) from Austria, Canada and the Netherlands. After revision of the item list, 26 items were considered eligible for pre-testing in phase III, in which 156 patients from Australia, Austria, Italy and Spain participated. All items passed criteria for pre-testing, thus forming the new EORTC QLQ-TC26. CONCLUSION: The newly developed EORTC QLQ-TC26 is now available in several languages to assess QOL in TC patients receiving treatment and in TC survivors. Phase IV of questionnaire development will comprise international field testing, including extensive analysis of psychometric characteristics of the EORTC QLQ-TC26.
format Online
Article
Text
id pubmed-3576569
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-35765692013-02-21 Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26 Holzner, Bernhard Efficace, Fabio Basso, Umberto Johnson, Colin D. Aaronson, Neil K. Arraras, Juan I. Smith, Allan B. Chow, Edward Oberguggenberger, Anne S. Bottomley, Andrew Steiner, Hannes Incrocci, Luca Giesinger, Johannes M. Qual Life Res Article OBJECTIVE: Testicular cancer (TC) is the most common cancer in young men, and its incidence is increasing. The low mortality rate makes quality of life (QOL) an important issue in this patient group. This study aimed to develop a supplementary module of the EORTC QLQ-C30 questionnaire to assess TC-specific aspects of QOL. METHODS: Questionnaire development was conducted according to guidelines from the EORTC Quality of Life Group. Phase I comprised generation of QOL issues relevant to TC patients through a literature search and interviews with patients and experts. Phase II included operationalization and assessment of item relevance. In phase III, items were pre-tested in a cross-cultural sample to assess issues such as understandability and intrusiveness of items. RESULTS: In phase I and II, an initial list of 69 QOL issues possibly relevant to TC patients was refined through patient and expert interviews. The remaining 37 issues were operationalized into items and assessed for relevance and priority in an expert sample (n = 28) and a patient sample (n = 62) from Austria, Canada and the Netherlands. After revision of the item list, 26 items were considered eligible for pre-testing in phase III, in which 156 patients from Australia, Austria, Italy and Spain participated. All items passed criteria for pre-testing, thus forming the new EORTC QLQ-TC26. CONCLUSION: The newly developed EORTC QLQ-TC26 is now available in several languages to assess QOL in TC patients receiving treatment and in TC survivors. Phase IV of questionnaire development will comprise international field testing, including extensive analysis of psychometric characteristics of the EORTC QLQ-TC26. Springer Netherlands 2012-03-10 2013 /pmc/articles/PMC3576569/ /pubmed/22407356 http://dx.doi.org/10.1007/s11136-012-0147-1 Text en © The Author(s) 2012 https://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Article
Holzner, Bernhard
Efficace, Fabio
Basso, Umberto
Johnson, Colin D.
Aaronson, Neil K.
Arraras, Juan I.
Smith, Allan B.
Chow, Edward
Oberguggenberger, Anne S.
Bottomley, Andrew
Steiner, Hannes
Incrocci, Luca
Giesinger, Johannes M.
Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26
title Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26
title_full Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26
title_fullStr Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26
title_full_unstemmed Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26
title_short Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26
title_sort cross-cultural development of an eortc questionnaire to assess health-related quality of life in patients with testicular cancer: the eortc qlq-tc26
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576569/
https://www.ncbi.nlm.nih.gov/pubmed/22407356
http://dx.doi.org/10.1007/s11136-012-0147-1
work_keys_str_mv AT holznerbernhard crossculturaldevelopmentofaneortcquestionnairetoassesshealthrelatedqualityoflifeinpatientswithtesticularcancertheeortcqlqtc26
AT efficacefabio crossculturaldevelopmentofaneortcquestionnairetoassesshealthrelatedqualityoflifeinpatientswithtesticularcancertheeortcqlqtc26
AT bassoumberto crossculturaldevelopmentofaneortcquestionnairetoassesshealthrelatedqualityoflifeinpatientswithtesticularcancertheeortcqlqtc26
AT johnsoncolind crossculturaldevelopmentofaneortcquestionnairetoassesshealthrelatedqualityoflifeinpatientswithtesticularcancertheeortcqlqtc26
AT aaronsonneilk crossculturaldevelopmentofaneortcquestionnairetoassesshealthrelatedqualityoflifeinpatientswithtesticularcancertheeortcqlqtc26
AT arrarasjuani crossculturaldevelopmentofaneortcquestionnairetoassesshealthrelatedqualityoflifeinpatientswithtesticularcancertheeortcqlqtc26
AT smithallanb crossculturaldevelopmentofaneortcquestionnairetoassesshealthrelatedqualityoflifeinpatientswithtesticularcancertheeortcqlqtc26
AT chowedward crossculturaldevelopmentofaneortcquestionnairetoassesshealthrelatedqualityoflifeinpatientswithtesticularcancertheeortcqlqtc26
AT oberguggenbergerannes crossculturaldevelopmentofaneortcquestionnairetoassesshealthrelatedqualityoflifeinpatientswithtesticularcancertheeortcqlqtc26
AT bottomleyandrew crossculturaldevelopmentofaneortcquestionnairetoassesshealthrelatedqualityoflifeinpatientswithtesticularcancertheeortcqlqtc26
AT steinerhannes crossculturaldevelopmentofaneortcquestionnairetoassesshealthrelatedqualityoflifeinpatientswithtesticularcancertheeortcqlqtc26
AT incrocciluca crossculturaldevelopmentofaneortcquestionnairetoassesshealthrelatedqualityoflifeinpatientswithtesticularcancertheeortcqlqtc26
AT giesingerjohannesm crossculturaldevelopmentofaneortcquestionnairetoassesshealthrelatedqualityoflifeinpatientswithtesticularcancertheeortcqlqtc26